These results firmly confirm that APR-246 induces early cell death in AML through ferroptosis and that APR-246 can synergistically promote cell death with ferroptosis inducers, whether through drug compounds or gene inactivation of SLC7A11 or GPX4, both in vivo and in vitro. This evidence concerns the gene GPX4 and acute myeloid leukemia.